Medicare Enrolled

Dr. Steven Kobetz, MD

Neurology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8940 N KENDALL DR, Miami, FL 33176
3055954041
In practice since 2006 (19 years)
NPI: 1326001280 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kobetz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kobetz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kobetz

Dr. Steven Kobetz is a neurology in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kobetz performed 1,275 Medicare services across 924 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kobetz received a total of $25,177 from 89 pharmaceutical and/or device companies across 1229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kobetz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 26% volume in FL$ $25,177 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,275
Medicare services
Top 26% in FL for neurology
924
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~67 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)622$102$562
New patient office visit (45-59 min)149$135$730
Annual depression screening139$19$77
Needle measurement of electrical activity in arm or leg muscles, complete study73$81$471
Administration of psychological or neuropsychological test by technician, each additional 30 minutes51$29$155
Measurement of brain wave activity (eeg), awake and drowsy44$309$1,599
Nerve conduction, 9-10 studies44$172$960
Office visit, established patient, complex (40-54 min)23$153$788
Evaluation of neuropsychological test, first hour17$108$560
Evaluation of neuropsychological test, each additional hour17$81$433
Administration of psychological or neuropsychological test by technician, first 30 minutes17$28$155
Test to assess balance during warm and cool irrigation in both ears15$33$177
Evaluation and testing for balance with recording15$84$465
Nerve conduction, 11-12 studies14$194$1,116
New patient office visit (30-44 min)12$98$494
Office visit, established patient (20-29 min)12$71$397
Ultrasound of both sides of head and neck blood flow11$162$1,037
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$25,177
Total received (2018-2024)
Avg $3,597/year across 7 years
Top 13% in FL for neurology
89
Companies
1,229
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,982 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$195 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,625
2023
$4,402
2022
$3,732
2021
$3,041
2020
$2,398
2019
$3,846
2018
$3,133

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,872
Amgen Inc.
$1,703
Teva Pharmaceuticals USA, Inc.
$1,373
UCB, Inc.
$1,366
Alexion Pharmaceuticals, Inc.
$989
Lilly USA, LLC
$809
Novartis Pharmaceuticals Corporation
$807
ACADIA Pharmaceuticals Inc
$804
Biogen, Inc.
$793
Allergan Inc.
$774
Neurocrine Biosciences, Inc.
$738
PFIZER INC.
$683
GENZYME CORPORATION
$611
Adamas Pharmaceuticals, Inc.
$533
ARGENX US, INC.
$500
Allergan, Inc.
$479
CSL Behring
$474
AbbVie Inc.
$465
US WorldMeds, LLC
$423
Lundbeck LLC
$404
Supernus Pharmaceuticals, Inc.
$360
Sunovion Pharmaceuticals Inc.
$359
Eisai Inc.
$353
Acorda Therapeutics, Inc
$324
EMD Serono, Inc.
$266
Otsuka America Pharmaceutical, Inc.
$254
IMPEL PHARMACEUTICALS INC.
$253
Amneal Pharmaceuticals LLC
$246
MITSUBISHI TANABE PHARMA AMERICA, INC.
$246
Biohaven Pharmaceutical Holding Company Ltd.
$234
Merz Pharmaceuticals, LLC
$224
Genentech USA, Inc.
$212
Neurelis, Inc.
$187
Avanir Pharmaceuticals, Inc.
$164
Biohaven Pharmaceuticals, Inc.
$163
Almatica Pharma LLC
$161
Kyowa Kirin, Inc.
$151
Akcea Therapeutics, Inc.
$148
Scilex Pharmaceuticals Inc.
$147
SK Life Science, Inc.
$144
Alnylam Pharmaceuticals Inc.
$139
Upsher-Smith Laboratories LLC
$138
Mallinckrodt Hospital Products Inc.
$128
AstraZeneca Pharmaceuticals LP
$124
Zyla Life Sciences
$118
Bausch Health US, LLC
$116
Corium, LLC
$115
Janssen Pharmaceuticals, Inc
$103
EISAI INC.
$101
Harmony Biosciences Llc
$95
Mallinckrodt LLC
$95
SCILEX PHARMACEUTICALS INC.
$94
GE HEALTHCARE
$87
UPSHER-SMITH LABORATORIES LLC
$82
IDORSIA PHARMACEUTICALS US INC
$80
Takeda Pharmaceuticals U.S.A., Inc.
$77
Averitas Pharma Inc.
$72
Mitsubishi Tanabe Pharma America, Inc.
$68
Impax Laboratories, Inc.
$68
MDD US Operations, LLC
$65
Alfasigma USA, Inc.
$63
Vertical Pharmaceuticals, LLC
$63
Azurity Pharmaceuticals, Inc.
$58
Grifols USA, LLC
$58
GRT US Holding, Inc.
$53
REVANCE THERAPEUTICS, INC.
$51
Zyla Life Sciences, Inc.
$51
Inspire Medical Systems, Inc.
$49
Harmony Biosciences LLC
$47
Assertio Therapeutics, Inc.
$45
Ipsen Biopharmaceuticals, Inc
$44
HARMONY BIOSCIENCES LLC
$43
Shire North American Group Inc
$38
Piramal Imaging Limited
$37
GE HealthCare
$31
Avion Pharmaceuticals
$31
Currax Pharmaceuticals LLC
$29
Egalet US Inc
$28
Vanda Pharmaceuticals Inc.
$23
AQUESTIVE THERAPEUTICS, INC.
$23
Bayer HealthCare Pharmaceuticals Inc.
$20
Sumitomo Pharma America, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$18
Promius Pharma LLC
$16
ASSERTIO THERAPEUTICS, Inc.
$16
ASSERTIO THERAPEUTICS, INC.
$15
Aprecia Pharmaceuticals, LLC
$14
Life Molecular Imaging Ltd
$14
LivaNova USA, Inc.
$13
Top 3 companies account for 23.6% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Apokyn · Austedo XR · Azstarys · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CITALOPRAM · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DAXXIFY · DUOPA · Dhivy · Dysport · EMGALITY · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · LEMTRADA · LORZONE · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · Ocrevus · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · PONVORY · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SYMPAZAN · Soliris · Spritam · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS Therapy · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,975 per 100 Medicare services performed
Looking for a neurology in Miami?
Compare neurologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
220
Per 100K population
8.2
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kobetz is a clinical cardiology specialist, with above-average Medicare volume (top 26% in FL), and high industry engagement (low-engagement, top 13%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kobetz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kobetz performed 622 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kobetz receive payments from pharmaceutical companies?
Yes. Dr. Kobetz received a total of $25,177 from 89 companies across 1,229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kobetz's costs compare to other neurologys in Miami?
Dr. Kobetz's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kobetz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →